Nine major articles appear in this issue of Neuro-Oncology 1999. The editorial by RosenbergArticle highlights the main points of each of these review articles. Current conventional therapies for brain tumors are presented in the papers by LevinArticle, PackerArticle, ShapiroArticle, and Perry et alArticle. The need for adequate pain control in patients with cancer is emphasized poignantly by FoleyArticle. Dalmau and PosnerArticle describe the neurobiological importance of paraneoplastic-related autoantibodies and their clinical implications. The theme issue concludes with 3 molecular studies by Hill et alArticle, Fueyo et alArticle, and Fathallah-ShaykhArticle. Molecular genetic changes in the glioma cell are described that offer unique strategies on which to capitalize in the development of effective new molecular therapies.
This Month in The Archives of Neurology. Arch Neurol. 1999;56(4):395. doi:10.1001/archneur.56.4.395